The 10-year rate of local recurrence was 39% (20/51) among HER2/neu+/Ki-67+ cases of DCIS compared with 18.5% (30/162) for cases without this profile (P=0.0024). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.